However, low doses of STZ have been shown to cause slight insulin secretion problems, as what happens in the later stages of type 2 diabetes.7,8 In the current study we used the HFD-low dose STZ model to produce features similar to type 2 diabetes in rats. This evidence concerns the gene INS and type 2 diabetes mellitus.